Well, I won my bet with myself, although there was little chance I would lose: As expected, the American media has utterly ignored the story that UK scientists have transformed umbilical cord blood stem cells into “mini livers,” not working livers, mind you, but liver tissue the size of a dime that can be used in drug testing and, hopefully, will one day be developed into a therapy for liver disease. Indian media reported it. So did Australian news. There was even a small report in Turkey.
Sadly, the research breakthrough just wasn’t up to rigorous US media standards since the scientists didn’t use the right kind of stem cells.
But they shouldn’t lose hope! They still have time to receive American media acclaim. All they have to do is go back to the lab and do it again—only this time with mouse embryonic stem cells. Then, the New York Times is sure to put their pictures on the front page.
YOU MIGHT ALSO LIKE
Restoring Man at Notre Dame
It is fascinating to be an outsider on the inside of an institution going through times of…
Deliver Us from Evil
In a recent New York Times article entitled “Freedom With a Side of Guilt: How Food Delivery…
Natural Law Needs Revelation
Natural law theory teaches that God embedded a teleological moral order in the world, such that things…
